GAIN-BCG: Gemcitabine Alternating With Intravesical BCG Randomized Against BCG Alone For Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer
- Sponsor:
- Alliance for Clinical Trials in Oncology
- Sponsor Study ID:
- A032303
- CTO #:
- 104249
- NCT Number:
- NCT07000084
- Phase:
- III
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Bladder
- Study Objectives:
- To compare high-grade recurrence-free-survival between treated with GemBCG compared to those treated with BCG alone.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Grubb, Robert, at grubbr@musc.edu
- Study Coordinator, Tucker, Renee, at tuckerr@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina, Ralph H. Johnson VAMC